Folgen
Marcel A. Müller
Marcel A. Müller
Professor, Institute of Virology, Charité Universitätsmedizin Berlin
Bestätigte E-Mail-Adresse bei charite.de
Titel
Zitiert von
Zitiert von
Jahr
SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor
M Hoffmann, H Kleine-Weber, S Schroeder, N Krüger, T Herrler, ...
cell 181 (2), 271-280. e8, 2020
226972020
Virological assessment of hospitalized patients with COVID-2019
R Wölfel, VM Corman, W Guggemos, M Seilmaier, S Zange, MA Müller, ...
Nature 581 (7809), 465-469, 2020
81052020
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
VS Raj, H Mou, SL Smits, DHW Dekkers, MA Müller, R Dijkman, D Muth, ...
Nature 495 (7440), 251-254, 2013
24752013
Severe acute respiratory syndrome coronavirus 2− specific antibody responses in coronavirus disease patients
NMA Okba, MA Müller, W Li, C Wang, CH GeurtsvanKessel, VM Corman, ...
Emerging infectious diseases 26 (7), 1478, 2020
16872020
SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19
J Braun, L Loyal, M Frentsch, D Wendisch, P Georg, F Kurth, ...
Nature 587 (7833), 270-274, 2020
13112020
Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response
I Glowacka, S Bertram, MA Müller, P Allen, E Soilleux, S Pfefferle, I Steffen, ...
Journal of virology 85 (9), 4122-4134, 2011
12892011
Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study
CBEM Reusken, BL Haagmans, MA Müller, C Gutierrez, GJ Godeke, ...
The Lancet infectious diseases 13 (10), 859-866, 2013
9412013
The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells
M Hoffmann, H Kleine-Weber, N Krüger, M Müller, C Drosten, ...
BioRxiv, 2020.01. 31.929042, 2020
9132020
Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction
VM Corman, I Eckerle, T Bleicker, A Zaki, O Landt, M Eschbach-Bludau, ...
Eurosurveillance 17 (39), 2012
7662012
Bats host major mammalian paramyxoviruses
JF Drexler, VM Corman, MA Müller, GD Maganga, P Vallo, T Binger, ...
Nature communications 3 (1), 796, 2012
7472012
Nafamostat mesylate blocks activation of SARS-CoV-2: new treatment option for COVID-19
M Hoffmann, S Schroeder, H Kleine-Weber, MA Müller, C Drosten, ...
Antimicrobial agents and chemotherapy 64 (6), 10.1128/aac. 00754-20, 2020
5232020
Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection
C Drosten, M Seilmaier, VM Corman, W Hartmann, G Scheible, S Sack, ...
The Lancet infectious diseases 13 (9), 745-751, 2013
5222013
Serological assays for emerging coronaviruses: challenges and pitfalls
B Meyer, C Drosten, MA Müller
Virus research 194, 175-183, 2014
5152014
Genomic characterization of severe acute respiratory syndrome-related coronavirus in European bats and classification of coronaviruses based on partial RNA-dependent RNA …
JF Drexler, F Gloza-Rausch, J Glende, VM Corman, D Muth, M Goettsche, ...
Journal of virology 84 (21), 11336-11349, 2010
4922010
Transmission of MERS-coronavirus in household contacts
C Drosten, B Meyer, MA Müller, VM Corman, M Al-Masri, R Hossain, ...
New England Journal of Medicine 371 (9), 828-835, 2014
4892014
Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections
VM Corman, MA Müller, U Costabel, J Timm, T Binger, B Meyer, P Kreher, ...
Eurosurveillance 17 (49), 20334, 2012
4822012
Viral shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection
VM Corman, AM Albarrak, AS Omrani, MM Albarrak, ME Farah, M Almasri, ...
Clinical Infectious Diseases 62 (4), 477-483, 2016
4782016
Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2
M Hoffmann, K Mösbauer, H Hofmann-Winkler, A Kaul, H Kleine-Weber, ...
Nature 585 (7826), 588-590, 2020
4752020
The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors
S Pfefferle, J Schöpf, M Kögl, CC Friedel, MA Müller, J Carbajo-Lozoya, ...
PLoS pathogens 7 (10), e1002331, 2011
4672011
Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform
T Thi Nhu Thao, F Labroussaa, N Ebert, P V’kovski, H Stalder, J Portmann, ...
Nature 582 (7813), 561-565, 2020
4632020
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20